The enhanced permeability and retention (EPR) effect observed in tumours and their surrounding tissues, coupled with the presence of specific receptors (Gp60, SPARC, FcRn) that are overexpressed in certain cancers, makes HSA-binding constructs an attractive tool for cancer diagnostics, therapy, and theranostics. The gene discussed is FCGRT; the disease is cancer.